Elevated B-type natriuretic peptide levels after anthracycline administration-Reference-Cited by-同舟云学术

Elevated B-type natriuretic peptide levels after anthracycline administration

Published:1998-08 Issue:2 Volume:136 Page:362-363
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Suzuki Toru,Hayashi Doubun,Yamazaki Tsutomu,Mizuno Takehiko,Kanda Yoshinobu,Komuro Issei,Kurabayashi Masahiko,Yamaoki Kazuhide,Mitani Kinuko,Hirai Hisamaru,Nagai Ryozo,Yazaki Yoshio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference6 articles.

1. Doxorubicin-induced cardiac toxicity;Doroshow;N Engl J Med,1991

2. Anthracycline-induced cardiotoxicity;Shan;Ann Intern Med,1996

3. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure;Yoshimura;Circulation,1993

4. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure;Yasue;Circulation,1994

5. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction;Omland;Circulation,1996

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natriuretic peptide testing strategies in heart failure: A 2023 update;Advances in Clinical Chemistry;2024

2. Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines;Journal of Personalized Medicine;2023-12-14

3. Cardiotoxicity;Side Effects of Cancer Therapy;2023-12-11

4. Anthracycline cardiotoxicity: current methods of diagnosis and possible role of 18F-FDG PET/CT as a new biomarker;Cardio-Oncology;2023-03-27

5. Advances in congestive heart failure biomarkers;Advances in Clinical Chemistry;2023